# Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy

> **NCT01201863** · PHASE4 · COMPLETED · sponsor: **Craig Hospital** · enrollment: 46 (actual)

## Conditions studied

- Endocrine Dysfunction
- Trauma
- Brain Injury

## Interventions

- **DRUG:** Androgel (Testosterone Gel)
- **OTHER:** Placebo gel

## Key facts

- **NCT ID:** NCT01201863
- **Lead sponsor:** Craig Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2021-07-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01201863

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01201863, "Neuroendocrine Dysfunction in Traumatic Brain Injury: Effects of Testosterone Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01201863. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*